Full Text View
Tabular View
Study Results
Related Studies
Bevacizumab in Treating Patients With Recurrent or Progressive Glioma
This study is ongoing, but not recruiting participants.
Study NCT00337207   Information provided by Northwestern University

First Received on June 13, 2006.   Last Updated on March 21, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Central Nervous System Neoplasms
Nervous System Neoplasms
More general conditions related to this trial
Neoplasms
Neoplasms by Site
Nervous System Diseases
Interventions listed in this trial
bevacizumab
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Northwestern University
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services